Literature DB >> 18353312

IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.

Ruolan Liu1, Ying Bai, Timothy L Vollmer, Xue-Feng Bai, Youngheun Jee, Yi-yuan Tang, Denise I Campagnolo, Mary Collins, Deborah A Young, Antonio La Cava, Fu-Dong Shi.   

Abstract

The IL-21 receptor (IL-21R) consists of a unique subunit and a common gamma chain (gamma(c)) that is shared with other cytokines including IL-2, IL-4, IL-7, and IL-15. The interaction between IL-21 and IL-21R results in significant effects on both innate and adaptive immune responses. In this study we examined the influence of IL-21R deficiency (IL-21R(-/-)) on the development of experimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS). IL-21R(-/-) mice developed EAE earlier and more severe neurological impairment than control mice, yet those mice could effectively recover from neurological deficits. The impact on EAE initiation by IL-21R deficiency was associated with a defect of CD4(+)CD25(+) T regulatory (Treg) cells and a down-regulated expression of Foxp3. The recovery from IL-21R(-/-) EAE was correlated with an expansion of Treg cells as well as an organ-specific redistribution of NK cells. These results suggest that a temporal influence of IL-21 on the activity of immunoregulatory circuits can be important in the modulation of the course of the autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18353312     DOI: 10.1016/j.expneurol.2007.11.004

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  17 in total

1.  Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.

Authors:  Keli L Hippen; Christoph Bucher; Dawn K Schirm; Amanda M Bearl; Ty Brender; Kathy A Mink; Kimberly S Waggie; Regis Peffault de Latour; Anne Janin; Julie M Curtsinger; Stacey R Dillon; Jeffrey S Miller; Gerard Socie; Bruce R Blazar
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.

Authors:  Y Li; V K Rauniyar; W F Yin; B Hu; S Ouyang; B Xiao; H Yang
Journal:  Neurol Sci       Date:  2013-05-26       Impact factor: 3.307

Review 3.  Development, regulation and functional capacities of Th17 cells.

Authors:  Keiji Hirota; Bruno Martin; Marc Veldhoen
Journal:  Semin Immunopathol       Date:  2010-01-27       Impact factor: 9.623

Review 4.  Th1 and Th17 cells: adversaries and collaborators.

Authors:  Jesse M Damsker; Anna M Hansen; Rachel R Caspi
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.

Authors:  Rafael M Rezende; Rafael P Oliveira; Samara R Medeiros; Ana C Gomes-Santos; Andrea C Alves; Flávia G Loli; Mauro A F Guimarães; Sylvia S Amaral; André P da Cunha; Howard L Weiner; Vasco Azevedo; Anderson Miyoshi; Ana M C Faria
Journal:  J Autoimmun       Date:  2012-08-28       Impact factor: 7.094

6.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

7.  Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity.

Authors:  Mary J Mattapallil; Jennifer L Kielczewski; Carlos R Zárate-Bladés; Anthony J St Leger; Kumarkrishna Raychaudhuri; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2019-05-09       Impact factor: 7.094

8.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

9.  IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation.

Authors:  Christoph Bucher; Lisa Koch; Christine Vogtenhuber; Emily Goren; Meghan Munger; Angela Panoskaltsis-Mortari; Pallavur Sivakumar; Bruce R Blazar
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

Review 10.  Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?

Authors:  M I Koenders; W B van den Berg
Journal:  Clin Exp Immunol       Date:  2009-11-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.